Molecular therapy for bone cancer: Curcumin inhibits the expression of histone demethylase KDM3A (JMJD1A/JHDM2A) via induction of its target gene, 25/December/2013, 6.23 am

Tumor suppression in bone cancer: Tumor suppressor p53 inhibits the expression of histone demethylase KDM3A (JMJD1A/JHDM2A) via induction of its target gene, 25/December/2013, 6.21 am
December 25, 2013
Insights into the pathogenesis of mastocytosis and allergies: p53, p63 and p73 enhance FcεRI-mediated degranulation in mast cells, 25/December/2013, 6.30 am
December 25, 2013

Idea Proposed byDr L Boominathan Ph.D.

Terms & Conditions apply http://genomediscovery.org/registration/terms-and-conditions/

To citeBoominathan, Molecular therapy for bone cancer: Curcumin inhibits the expression of histone demethylase KDM3A (JMJD1A/JHDM2A) via induction of its target gene, 25/December/2013, 6.23 am,Genome-2-Bio-Medicine Discovery center (GBMD), http://genomediscovery.org

* Research cooperation

Comments are closed.